Logo

BioDiscovery, OGT Settle Microarray-Software Patent-Infringement Suit

Oct 23, 2003

NEW YORK, Oct. 23 (GenomeWeb News) - BioDiscovery and Oxford Gene Technology have settled the patent-infringement lawsuit filed by OGT in December 2002, the companies said today.

 

Terms of the settlement, which revolve around US Patent No. 6,054,270, allow BioDiscovery to continue selling its full line of microarray-image and data-analysis software, but does not give it a license to any OGT patents.

 

BioDiscovery's software "may not be used to make any oligonucleotide arrays coming within the scope of any OGT patent or analyze polynucleotides using oligonucleotide arrays coming within the scope of any OGT patent or according to any method claimed in any OGT Patent, unless the user has a license from OGT or uses arrays made by licensees of OGT," the companies said.

Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.